Using opportunistic screening for low bone mineral density (BMD) has the potential to overcome the substantial diagnostic gap of patients eligible for osteoporosis treatment. This work evaluates the in vivo application of BMD measurements based on Dual-Layer Spectral Computed Tomography (DLCT) using virtual monoenergetic images at different energy levels. In summary, DLCT allows for BMD assessment in virtually all routine clinical DLCT data, either via direct measurements in native scans or with adjustments for vascular iodine in contrast-enhanced examinations.
«
Using opportunistic screening for low bone mineral density (BMD) has the potential to overcome the substantial diagnostic gap of patients eligible for osteoporosis treatment. This work evaluates the in vivo application of BMD measurements based on Dual-Layer Spectral Computed Tomography (DLCT) using virtual monoenergetic images at different energy levels. In summary, DLCT allows for BMD assessment in virtually all routine clinical DLCT data, either via direct measurements in native scans or with...
»